Taxi-based advertising service Firefly has raised $30m from investors including GV, and acquired Strong Outdoor’s digital operations.
Author: Callum Cyrus
Prowler.io pounces on $24m
Pearson, Tencent and Mandatum Life helped supply the AI forecasting platform developer with series B capital that took its total funding to $39m.
Storm attracts more series A funding
M Ventures, Pfizer Ventures and Taiho Ventures all returned to help boost cancer drug developer Storm Therapeutics’ series A round to $38.2m.
Arm lends a hand to Blu Wireless
Arm has co-led a $16.6m round for wireless connectivity technology provider Blu Wireless, two years after leading its series B.
Icometrix processes $18m in funding
Optum Ventures co-led a round for Icometrix, the developer of a diagnostics system for neurological disorders, with Forestay Capital and Capricorn Venture Partners.
Algorithmia computes $25m series B
Gradient Ventures and Rakuten Ventures contributed to the machine learning software developer’s latest round, which brought its overall funding to nearly $38m.
Twentyeight-Seven recalculates series A round
Johnson & Johnson, Novartis and Astellas all took part in the first close of a round for oncology therapy developer 28-7 Therapeutics that now stands at $82.8m.
Neural Analytics nets $22m
TigerMed-backed brain monitor developer Neural Analytics boosted its total funding to $66m in a series C round led by existing investor Alpha Edison.
Congenica coaxes DC Health for series B extension
Digital China Health Technologies chipped into the third tranche of a round featuring fellow corporates BGI Genomics and Healthlink that now tops $30m.
Genentech helps generate funding for Start Codon
Genentech, University of Cambridge and Babraham Bioscience Technologies have backed accelerator Start Codon, which plans to work with some 50 life sciences startups.
Nocion plays nice to raise $27m
Nocion Therapeutics has raised $27m in a Partners Innovation Fund-backed series A round to develop drugs for pain and inflammation.
Banks enliven EdiGene’s series B round
FujiFilm-backed genetic disorder drug developer EdiGene has secured $14.3m from investors including SBI Investment, SMBC Capital and Mizuho Capital.
Trumpf shows RSP respect in series B round
Corporate venturing unit Trumpf Venture invested $4.5m to help the diabetes monitor developer close the round at $12.1m.
News round up 24 September 2018
A round up of all the news on www.globalcorporateventuring.com for our subscribers.